Anti-viral Drugs Market Size, Share, Growth

Anti-viral Drugs Market

Anti-viral Drugs Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: Jan 2026 | Format: | No. of Pages: 200

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Sample / Information

FAQ : Anti-viral Drugs Market

The Anti-viral Drugs Market size is valued at USD 87.4 Bn in 2026.

The Anti-viral Drugs Market is projected to grow at a 5% CAGR by 2033.

The market growth is driven by rising prevalence of viral infections, increasing healthcare spending, and advancements in antiviral therapies.

North America is the dominating region for the anti-viral drugs market.

Gilead Sciences, GlaxoSmithKline, AbbVie, Merck & Co., and Pfizer are some leading industry players in the anti-viral drugs market.